Healthyways Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-06-2024
- Paid Up Capital ₹ 0.10 M
as on 21-06-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.48 M
as on 21-06-2024
- Revenue 5.91%
(FY 2022)
- Profit 4.10%
(FY 2022)
- Ebitda 350.09%
(FY 2022)
- Net Worth 46.79%
(FY 2022)
- Total Assets 5.82%
(FY 2022)
About Healthyways Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.48 M.
Sachin Suri and Ritu Suri serve as directors at the Company.
- CIN/LLPIN
U51397DL2010PTC209936
- Company No.
209936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Healthyways Pharmaceuticals Private Limited offer?
Healthyways Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Mental Wellness, Vitamins & Supplements, Multivitamins, Mineral Supplements, Specialty Supplements, Probiotics.
Who are the key members and board of directors at Healthyways Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Suri  | Director | 28-Mar-2015 | Current |
| Ritu Suri | Director | 28-Oct-2010 | Current |
Financial Performance of Healthyways Pharmaceuticals.
Healthyways Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.91% increase. The company also saw a slight improvement in profitability, with a 4.1% increase in profit. The company's net worth Soared by an impressive increase of 46.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healthyways Pharmaceuticals?
In 2019, Healthyways Pharmaceuticals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Jun 2023 | ₹2.35 M | Open |
Others Creation Date: 22 Mar 2021 | ₹1.13 M | Open |
How Many Employees Work at Healthyways Pharmaceuticals?
Unlock and access historical data on people associated with Healthyways Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthyways Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthyways Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
